About SANARIA INC.
Sanaria is a biotechnology company developing vaccines protective against malaria, with vaccines proven highly effective against Plasmodium falciparum infection in humans. The company aims to prevent malaria in individuals and contribute to community-level eradication through vaccination.
Development of malaria vaccinesClinical trials for malaria vaccinesResearch and development in Plasmodium falciparum sporozoite (PfSPZ) vaccine technologyCollaboration with global organizations for malaria eradication
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| ASEXUAL MALARIA BLOOD CULTURE SERVICE FOR NCATS | Department of Health and Human Services | $89K | |
| SANARIA INC | Department of Health and Human Services | $299K | |
| Federal contract award | Department of Health and Human Services | $304K | |
| Federal contract award | Department of Health and Human Services | $43K | |
| PFSPZ REAGENTS BIOLOGICAL KITS (AMBIS #2228227) | Department of Health and Human Services | $64K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to SANARIA INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.